Vicore and Endeavor’s therapies show promise in treating IPF
Both drugs have the potential to offer a disease-modifying approach to the lung disease
Read More
Author: Jen Brogan
Liverpool and McMaster University announce £300,000 strategic research partnership
Areas include health research across life stages, from paediatrics to health ageing and resilience
Read More
Study finds link between malaria parasites developing antimalarial drug resistance
Spread through Anopheles mosquitoes, the disease affected around 249 million people globally in 2022
Read More
Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
The cardiovascular disease, pulmonary arterial hypertension, affects around 6,500 people in the UK
Read More
Closed Loop and Pharmanovia investigate precision medicine combination in hypertension
The OptiZest study aims to investigate a personalised dose of Zestril in these patients
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
